{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-165656","form_type":"8-K","ticker":"AURA","cik":"0001501796","company_name":"Aura Biosciences, Inc.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.704371+00:00","generated_at":"2026-06-01T02:49:02.351114+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aura Biosciences shareholders approve officer exculpation amendment, re-elect directors","bullets":["Amendment to Tenth Amended Certificate limits officer liability per Delaware law; effective June 20, 2024.","Directors Antony Mattessich (28.3M for) and Sapna Srivastava (31.9M for) re-elected as Class III directors.","Ernst & Young ratified as independent auditor for FY 2024 with 38.7M votes for, 5,843 against.","Charter amendment filed as Exhibit 3.1; all proposals passed with broker non-votes on first two items."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-165656","json":"https://secwatch.observer/filing/0001193125-24-165656.json","markdown":"https://secwatch.observer/filing/0001193125-24-165656.md","text":"https://secwatch.observer/filing/0001193125-24-165656.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501796/000119312524165656/0001193125-24-165656-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501796/000119312524165656/d783830d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:49:02.351114+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}